This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Melanoma in situ of lower limb, including hip
CD2_INSITU_MELANOMA_LOWERLIMB
melanoma: A malignant, usually aggressive tumor composed of atypical, neoplastic melanocytes. Most often, melanomas arise in the skin (cutaneous melanomas) and include the following histologic subtypes: superficial spreading melanoma, nodular melanoma, acral lentiginous melanoma, and lentigo maligna melanoma. Cutaneous melanomas may arise from acquired or congenital melanocytic or dysplastic nevi. Melanomas may also arise in other anatomic sites including the gastrointestinal system, eye, urinary tract, and reproductive system. Melanomas frequently metastasize to lymph nodes, liver, lungs, and brain.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
200 |
4. Check minimum number of eventsNone |
200 |
5. Include endpointsNone |
200 |
6. Filter based on genotype QC (FinnGen only) |
200 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D03
- Name in latin
- Melanoma in situ coxae
Similar endpoints
↥List of similar endpoints to
Melanoma in situ of lower limb, including hip
based on the number of shared cases.
Similar with more cases:
- Melanoma in situ of lower limb, including hip
- Melanoma in situ
- Melanoma in situ
- Malignant melanoma
- Malignant melanoma, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 200 | 152 | 48 |
| Unadjusted period prevalence (%) | 0.04 | 0.05 | 0.02 |
| Median age at first event (years) | 64.05 | 62.01 | 70.52 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 173
- Matched controls
- 1728
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D03.7
ICD-10 Finland
Melanoma in situ of lower limb, including hip
+∞
250.2
173
*
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
186.1
118.7
115
18
8720/2-C44.9
ICD-O-3
Melanoma in situ of skin, NOS
141.9
41.9
43
*
D22.7
ICD-10 Finland
Melanocytic naevi of lower limb, including hip
59.1
35.6
41
9
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
11.0
32.7
69
98
D22.9
ICD-10 Finland
Melanocytic naevi, unspecified
23.6
31.9
46
26
D22.5
ICD-10 Finland
Melanocytic naevi of trunk
13.7
26.8
48
47
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
10.5
24.3
50
64
C43.72
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip: 'superficial spreading' type
+∞
21.3
20
*
R23.8
ICD-10 Finland
Other and unspecified skin changes
5.6
18.3
61
153
C43.70
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip without histology
187.2
16.8
17
*
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
8.8
16.3
36
50
C43.79
ICD-10 Finland
Malignant melanoma of the lower extremity including hip or other unspecified histology
+∞
15.9
15
*
D22
ICD-10 Finland
Melanocytic naevi
11.3
14.9
28
29
8720/3-C44.7
ICD-O-3
Malignant melanoma, NOS, of skin of lower limb and hip
81.3
13.8
15
*
S18
ICPC
Laceration/cut
3.4
13.3
105
538
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
12.4
13.0
23
21
L57.0
ICD-10 Finland
Actinic keratosis
5.3
12.6
41
96
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
12.4
12.4
22
20
C43.7
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of lower limb, including hip
+∞
11.6
11
*
ZZA00
NOMESCO Finland
Split skin graft
11.2
11.4
21
21
QDE99
NOMESCO Finland
Other excision or repair of lesion of skin of lower limb
27.1
11.3
15
6
8720/3-C44.9
ICD-O-3
Malignant melanoma, NOS, of skin, NOS
30.2
10.9
14
5
D03.5
ICD-10 Finland
Melanoma in situ of trunk
64.0
10.8
12
*
XQ846
NOMESCO Finland
Digital dermatoscopy and registration of nevi
116.7
10.5
11
*
S77
ICPC
Malignant neoplasm of skin
19.9
9.1
13
7
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
4.7
9.1
31
76
8720/2-C44.7
ICD-O-3
Melanoma in situ of skin of lower limb and hip
+∞
8.4
8
*
C43.73
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip nodular
+∞
8.4
8
*
C44.71
ICD-10 Finland
Basocellular carcinoma of the skin of the lower extremity including the hip
35.1
8.2
10
*
TQW99
NOMESCO Finland
Other minor procedure on skin
5.4
7.8
23
48
L82
ICD-10 Finland
Seborrhoeic keratosis
3.1
7.6
45
175
C43
ICD-10 Finland
Malignant melanoma of skin
83.5
7.5
8
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
5.0
7.4
23
51
C43.59
ICD-10 Finland
Malignant melanoma of the trunk other or unspecified histology
31.4
7.2
9
*
ZZR00
NOMESCO Finland
Flap of skin
9.4
7.2
14
16
S82
ICPC
Naevus/mole
3.4
7.0
35
121
8090/3-C44.7
ICD-O-3
Basal cell carcinoma, NOS, of skin of lower limb and hip
41.7
6.8
8
*
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
9.3
6.7
13
15
8742/2-C44.9
ICD-O-3
Lentigo maligna of skin, NOS
72.4
6.5
7
*
D03.6
ICD-10 Finland
Melanoma in situ of upper limb, including shoulder
72.4
6.5
7
*
C43.71
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip originating in lentigo maligna
+∞
6.3
6
*
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
5.4
6.1
17
34
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3002256) Pathology report gross observation
111
209
10.69
65.01
1.9
1.2
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
174
726
11.74
42.77
4.3
2.1
—
—
—
0
0
(4035726)
60
171
4.58
19.91
1.5
1.3
—
—
—
0
0
(40768443) Skin Pathology biopsy report
32
82
4.46
11.82
1.6
1.3
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
183
1608
2.62
3.76
17.3
13.2
ml/min/173m2
77.9
78.2
0.05
152
1317
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
11
30
3.82
3.69
1.5
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
11
30
3.82
3.69
1.5
1.3
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
80
550
1.76
3.58
8.9
5.2
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
194
1797
3.65
3.46
12.5
10.4
u/l
24.5
24.5
0.02
188
1725
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
13
44
3.09
3.20
1.3
1.3
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
43
258
1.85
2.96
2.3
2.9
e6/l
1.5
2.8
0.88
20
138
(3013115) Eosinophils [#/volume] in Blood
111
874
1.61
2.75
8.6
5.9
e9/l
0.2
0.2
0.02
100
769
(3000494) Fungus identified in Specimen by Culture
38
225
1.85
2.72
1.4
1.3
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
45
281
1.78
2.72
2.6
2.7
e6/l
0.4
1.0
1.70
22
157
(3013650) Neutrophils [#/volume] in Blood by Automated count
123
999
1.60
2.63
9.8
9.2
e9/l
3.9
4.0
0.03
109
874
(3035637) Corticotropin [Mass/volume] in Plasma
7
16
4.49
2.49
1.9
1.6
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
72
521
1.60
2.48
1.9
2.0
u/l
327.3
328.0
0.00
66
488
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
11
41
2.78
2.32
1.3
1.6
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
0
60
0.00
2.29
0.0
4.2
—
3.9
—
0
53
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
8
24
3.43
2.20
1.1
1.4
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
105
845
1.51
2.18
8.4
5.5
e9/l
0.6
0.6
0.95
94
732
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
183
1680
2.05
2.17
4.1
4.6
mmol/l
4.6
4.7
0.87
171
1539
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
17
82
2.17
2.14
3.4
9.0
mmol/l
23.7
24.9
1.40
17
76
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
186
1719
2.17
2.13
4.8
5.2
mmol/l
2.7
2.7
0.56
172
1563
(3006315) Basophils [#/volume] in Blood
105
848
1.50
2.12
8.5
5.5
e9/l
0.0
0.0
0.92
94
732
(3019198) Lymphocytes [#/volume] in Blood
106
860
1.49
2.08
8.4
5.6
e9/l
1.9
2.0
0.16
96
763
(3024891) Influenza virus A+B Ag [Presence] in Specimen
11
44
2.59
2.05
1.2
1.1
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
181
1668
1.90
1.92
4.6
4.7
mmol/l
5.7
5.9
3.36
167
1518
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
92
737
1.46
1.87
2.3
2.3
nmol/l
85.6
78.7
1.62
86
642
(3038515) Glucose [Moles/volume] in Venous blood
0
46
0.00
1.73
0.0
2.9
—
7.2
—
0
46
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
29
182
1.69
1.72
3.7
3.0
ug/l
0.8
0.7
0.11
21
129
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
5
13
3.91
1.72
1.4
1.2
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
0
48
0.00
1.72
0.0
2.9
—
1.5
—
0
48
(3042936) Bacteria identified in Isolate by Culture
36
241
1.60
1.68
1.8
1.9
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
11
49
2.32
1.67
1.4
1.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
180
1671
1.77
1.64
4.1
4.5
mmol/l
1.6
1.5
0.10
168
1518
(3014765) Yersinia sp identified in Stool by Organism specific culture
12
56
2.22
1.64
1.2
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
12
57
2.18
1.58
1.2
1.2
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
59
447
1.45
1.56
3.5
2.9
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
97
811
1.38
1.45
9.5
5.8
%
27.1
28.0
0.38
91
743
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
6
22
2.78
1.44
1.7
1.1
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
18
104
1.80
1.42
1.4
1.7
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
188
1781
1.93
1.40
18.9
16.5
umol/l
76.2
75.4
0.14
188
1781
(3047007) Chlamydophila sp Ab [Presence] in Serum
6
23
2.66
1.38
1.2
1.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
163
1495
1.49
1.37
20.0
15.2
%
40.3
39.5
1.31
118
1061
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
28
187
1.58
1.33
1.6
1.8
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
5
18
2.82
1.29
1.2
1.0
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
171
1589
1.53
1.29
5.5
5.9
mmol/mol
38.5
39.9
1.65
157
1469
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
179
1682
1.61
1.25
16.9
14.0
mg/l
23.6
21.4
0.33
139
1313
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
6
25
2.44
1.25
1.7
1.2
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
59
464
1.39
1.25
3.5
3.0
e6/l
0.4
0.5
0.12
41
343
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
11
56
2.02
1.24
1.1
1.2
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
51
392
1.40
1.23
1.5
1.3
—
—
—
0
0
(3018418) pH of Serum or Plasma
69
559
1.36
1.21
3.5
4.0
ph
7.4
7.4
0.15
13
89
(3000492) Spirometry study
22
142
1.62
1.20
1.6
1.5
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
37
269
1.46
1.20
1.6
1.9
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
11
57
1.98
1.19
4.4
1.4
ug/l
592.2
927.9
0.16
11
52
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
54
674
0.73
1.18
3.7
3.7
—
—
—
0
0
(3022145) Colonoscopy Study observation
31
218
1.50
1.18
1.7
1.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
17
103
1.71
1.17
1.2
1.2
—
—
—
0
0
(3019060) Gas panel - Arterial blood
5
114
0.42
1.16
2.8
4.9
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
5
20
2.54
1.16
1.8
1.2
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
102
881
1.32
1.15
4.8
6.6
mmol/l
1.2
1.2
1.01
90
758
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
95
813
1.32
1.14
4.8
5.6
mmol/l
1.2
1.2
0.48
89
732
(3026389) Candida sp identified in Specimen by Organism specific culture
5
21
2.42
1.09
1.0
1.6
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
49
383
1.37
1.07
4.1
1.8
mg/l
5.6
1.0
0.55
35
313
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
27
189
1.50
1.06
1.6
1.9
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
63
513
1.33
1.06
3.1
3.1
e6/l
9.9
175.2
0.71
45
389
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
9
46
2.00
1.05
1.6
1.4
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
5
22
2.30
1.04
1.4
1.4
—
—
—
0
0
(4281824)
5
22
2.30
1.04
1.2
1.0
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
27
190
1.49
1.04
1.7
1.6
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
50
395
1.35
1.02
2.2
2.1
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
54
432
1.34
1.02
1.6
1.6
nmol/l
25.6
22.2
0.82
47
361
(1616796) Gas panel - Central venous blood
7
35
2.04
1.01
3.1
2.4
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
147
1351
1.33
1.00
9.1
7.1
u/l
74.6
76.5
0.42
141
1248
(3018095) Leukocytes [#/volume] in Urine
73
612
1.30
0.99
3.8
3.7
e6/l
27.3
63.9
1.33
47
424
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
19
125
1.57
0.98
1.7
1.7
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
0
32
0.00
0.96
0.0
2.7
—
106.4
—
0
32
(3033705) Calcium.ionized [Moles/volume] in Venous blood
0
32
0.00
0.96
0.0
2.7
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
0
32
0.00
0.96
0.0
2.7
—
3.9
—
0
32
(40760892) CBC W Ordered Manual Differential panel - Blood
48
381
1.34
0.95
4.3
5.1
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
7
37
1.92
0.95
1.1
2.2
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
7
37
1.92
0.95
1.0
1.4
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
14
86
1.68
0.93
4.4
8.2
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
36
275
1.38
0.91
2.5
2.9
mmol/l
0.8
0.8
0.32
36
256
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
30
222
1.41
0.90
4.0
4.6
%
33.0
32.8
0.03
22
132
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
20
282
0.68
0.87
2.1
1.4
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
15
96
1.61
0.87
4.7
5.4
mmol/l
24.5
25.0
0.24
15
96
(3012544) pH of Venous blood
10
165
0.59
0.86
3.7
3.7
—
—
—
0
0
(4010399)
19
130
1.51
0.84
1.5
1.4
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
110
988
1.25
0.82
2.7
2.8
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
86
752
1.25
0.81
12.4
9.6
e9/l
0.0
0.0
0.13
69
618
(44816559) Phosphatidylethanol [Mass/volume] in Blood
0
26
0.00
0.79
0.0
1.2
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
0
27
0.00
0.78
0.0
3.3
—
1.6
—
0
22
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
71
610
1.25
0.77
3.3
3.0
—
—
—
0
0
(40758558) Short blood count panel - Blood
54
450
1.27
0.76
8.5
6.9
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
118
1075
1.24
0.75
3.3
3.0
u/l
38.3
44.9
0.70
107
1002
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
14
92
1.56
0.74
1.5
1.4
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
9
56
1.64
0.73
1.3
1.4
—
—
—
0
0
(3000991) Gas panel - Venous blood
18
126
1.47
0.73
4.6
7.8
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
15
101
1.52
0.72
1.3
1.3
u/ml
282.8
165.7
0.22
15
91
(3044640) Blood type and Crossmatch panel - Blood
63
539
1.25
0.71
2.3
2.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
13
85
1.57
0.71
1.2
1.3
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
28
1.81
0.66
1.0
1.0
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
169
1613
1.31
0.66
3.8
4.0
mmol/l
1.3
1.3
0.22
155
1461
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
22
164
1.38
0.66
3.7
3.4
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
31
245
1.31
0.65
4.6
4.5
%
20.7
20.8
0.01
19
126
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
5
29
1.74
0.64
3.0
3.0
%
63.8
62.2
—
5
29
(3030905) Polymorphonuclear cells [#/volume] in Blood
5
29
1.74
0.64
3.0
2.4
e9/l
4.8
5.2
—
5
29
(3037467) Urinalysis macro (dipstick) panel - Urine
127
1178
1.21
0.63
5.3
4.3
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
13
88
1.51
0.62
1.1
1.0
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
0
20
0.00
0.60
0.0
1.5
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
66
577
1.21
0.60
2.5
3.0
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
25
317
0.76
0.60
1.3
1.3
u/ml
10.9
16.8
—
10
119
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
58
665
0.82
0.60
2.8
3.7
ng/l
30.7
37.0
0.14
37
470
(3008757) Leukocyte morphology finding [Identifier] in Blood
0
22
0.00
0.59
0.0
2.7
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
18
132
1.40
0.59
4.2
2.9
u/ml
19.7
40.7
1.07
18
127
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
0
23
0.00
0.58
0.0
1.2
—
7.6
—
0
13
(3013707) Erythrocyte sedimentation rate by Westergren method
139
1306
1.21
0.58
4.8
4.2
mm/h
9.6
12.7
3.13
127
1182
(3009214) Lutropin [Units/volume] in Serum or Plasma
6
36
1.69
0.57
1.3
1.2
u/l
15.2
15.8
—
6
28
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
79
707
1.19
0.56
2.1
2.0
pmol/l
95.4
97.3
0.11
34
341
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
22
169
1.34
0.56
2.0
1.5
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
6
37
1.64
0.56
4.3
2.9
kpa
8.0
8.8
—
6
37
(3013290) Carbon dioxide [Partial pressure] in Blood
6
37
1.64
0.56
4.3
2.9
kpa
5.3
5.0
—
6
37
(3012501) Base excess in Blood by calculation
6
37
1.64
0.56
4.3
2.9
mmol/l
-0.2
2.5
—
6
21
(3026493) Urate [Moles/volume] in Serum or Plasma
52
447
1.22
0.56
2.4
2.8
umol/l
353.7
9417.9
2.97
46
377
(3045414) Leukocytes [Presence] in Urine
9
60
1.52
0.55
1.4
1.7
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
26
206
1.30
0.54
2.0
1.6
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
24
188
1.31
0.54
1.4
2.6
umol/l
4.7
6.8
1.41
18
166
(3049717) Cytology report of Urine Cyto stain
9
62
1.47
0.54
1.9
2.9
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
6
39
1.55
0.53
1.2
1.5
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
9
64
1.43
0.52
1.0
1.0
—
—
—
0
0
(40761535) Cells panel - Urine sediment
10
144
0.68
0.51
4.8
3.1
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
19
145
1.34
0.51
4.6
5.9
mmol/l
1.2
1.3
0.32
19
139
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
167
1606
1.24
0.50
5.3
4.9
mu/l
1.9
1.9
0.05
159
1456
(3048689) Calprotectin [Mass/mass] in Stool
26
209
1.28
0.49
2.4
2.0
ug/g
78.9
134.7
0.86
15
165
(3022948) Iron [Moles/volume] in Serum or Plasma
33
274
1.24
0.49
2.9
2.4
umol/l
12.9
13.6
0.25
27
249
(40768793) Breast Pathology biopsy report
10
68
1.50
0.48
1.2
1.4
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
41
350
1.22
0.47
2.9
2.5
e6/l
2.7
5.3
2.64
35
306
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
26
211
1.27
0.46
4.8
7.0
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
7
49
1.44
0.46
1.1
1.1
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
143
1360
1.18
0.46
4.3
4.0
pmol/l
15.0
14.8
0.49
135
1223
(3017143) Hepatitis C virus Ab [Presence] in Serum
19
148
1.31
0.45
2.3
1.5
—
—
—
0
0
(3019225) pH of Specimen
21
167
1.29
0.44
4.0
4.3
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
17
131
1.33
0.44
3.8
3.6
—
—
—
0
0
(3013512) EKG study
58
516
1.17
0.43
3.3
3.8
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
5
31
1.63
0.43
1.6
1.5
u/l
51.2
42.1
—
5
25
(3026008) Bacteria identified in Urine by Culture
49
554
0.85
0.42
4.0
3.0
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
15
114
1.34
0.42
2.2
1.4
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
5
33
1.53
0.41
5.8
2.0
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
5
33
1.53
0.41
2.0
1.3
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
0
15
0.00
0.41
0.0
3.6
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.1
—
18.0
—
0
15
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
15
0.00
0.41
0.0
3.6
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
12
88
1.39
0.41
1.4
1.4
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
57
509
1.17
0.41
2.8
3.0
mg/l
10.7
177.9
0.68
33
310
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
17
0.00
0.41
0.0
2.7
—
13.6
—
0
17
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
37
318
1.20
0.40
6.6
5.1
ug/l
2.9
3.2
0.08
32
280
(3024928) Oxygen saturation in Venous blood
5
34
1.48
0.40
3.4
2.7
—
—
—
0
0
(3026782) Osmolality of Urine
39
337
1.20
0.40
2.4
2.7
mosm/kgh2o
583.7
539.4
0.49
31
282
(3017354) Segmented neutrophils/100 leukocytes in Blood
0
18
0.00
0.40
0.0
2.2
—
61.5
—
0
11
(3004588) Protein electrophoresis panel - Serum or Plasma
16
124
1.32
0.40
1.6
3.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
9
67
1.36
0.38
2.3
4.6
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
39
339
1.19
0.38
3.2
3.3
ng/l
65.2
216.7
0.79
29
263
(3022621) pH of Urine by Test strip
9
122
0.73
0.36
1.3
2.7
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
6
42
1.44
0.36
4.7
3.0
u/ml
40.8
32.1
—
6
42
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
84
779
1.14
0.35
3.5
3.9
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
6
43
1.41
0.35
3.7
1.2
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
28
327
0.83
0.35
1.4
1.3
iu/ml
45.4
41.9
—
8
107
(3010421) pH of Blood
6
44
1.37
0.34
4.8
3.0
ph
7.4
7.4
—
6
37
(3000330) Specific gravity of Urine by Test strip
6
89
0.66
0.33
1.7
3.8
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
68
625
1.13
0.33
4.3
3.1
mmol/l
2.3
2.4
0.30
60
539
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
62
568
1.13
0.31
2.6
2.9
u/l
26.8
30.8
0.94
55
541
(3004789) Transferrin [Mass/volume] in Serum or Plasma
29
251
1.18
0.30
3.0
2.3
g/l
2.1
2.4
1.64
24
228
(3052851) Hemolysis interference index of Serum or Plasma
7
56
1.26
0.29
2.3
3.4
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
50
454
1.14
0.29
4.9
3.8
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
43
474
0.88
0.27
2.6
3.3
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
8
67
1.20
0.26
1.5
1.9
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
15
181
0.81
0.26
4.5
7.3
%
95.1
95.8
0.15
15
174
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
54
497
1.12
0.25
1.5
1.7
mmol/l
1.5
1.4
0.39
47
420
(3023520) Reticulocytes [#/volume] in Blood
17
143
1.21
0.24
1.8
3.2
e9/l
67.1
68.4
—
7
111
(3009508) Creatinine [Moles/volume] in Urine
57
528
1.11
0.24
2.7
2.9
mmol/l
6.8
6.9
0.09
47
430
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
7
92
0.75
0.23
2.7
2.5
%
1.6
1.1
—
7
92
(3004451) EKG impression Narrative
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.2
—
1.8
—
0
11
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
0
10
0.00
0.21
0.0
1.0
—
28.4
—
0
10
(21491868) Cryoglobulin [Mass/volume] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
10
0.00
0.21
0.0
1.1
—
5.9
—
0
10
(3035933) Granulocytes/100 leukocytes in Blood
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
12
0.00
0.21
0.0
7.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
9
111
0.80
0.20
1.6
1.3
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
14
0.00
0.20
0.0
1.9
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
79
751
1.09
0.19
2.8
2.6
ug/l
130.6
109.0
0.50
73
687
(3013826) Glucose [Moles/volume] in Serum or Plasma
103
993
1.08
0.17
4.0
4.4
mmol/l
6.4
6.6
0.60
93
928
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
7
62
1.13
0.17
1.7
2.2
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
22
196
1.14
0.17
3.4
7.1
kpa
11.7
11.8
0.05
22
189
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
22
196
1.14
0.17
3.4
7.1
kpa
5.1
5.2
0.15
22
189
(3003327) Ova and parasites identified in Stool by Light microscopy
7
63
1.12
0.17
2.4
1.5
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
11
92
1.21
0.16
2.3
2.5
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
43
460
0.92
0.16
3.9
3.8
estimate
0.0
0.0
0.00
13
146
(3019832) Treponema pallidum Ab [Presence] in Serum
8
73
1.10
0.16
2.4
1.5
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
9
78
1.16
0.15
1.0
1.3
iu/l
27.4
31.6
—
9
68
(3014007) Fractional oxyhemoglobin in Arterial blood
12
102
1.19
0.15
4.3
8.4
%
93.7
94.5
0.15
12
102
(21494755) Public health laboratory ask at order entry panel
14
121
1.17
0.15
1.3
1.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
18
160
1.14
0.14
1.9
1.6
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
178
1758
1.11
0.14
13.5
13.1
—
—
—
0
0
(3044889) 12 lead EKG panel
119
1216
0.95
0.11
4.0
3.9
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
5
45
1.11
0.10
1.0
1.1
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
5
47
1.07
0.09
1.8
1.2
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
5
48
1.04
0.09
1.4
2.2
mmol/l
24.4
25.8
—
5
38
(3017446) Testosterone [Moles/volume] in Serum or Plasma
7
66
1.06
0.08
3.4
2.0
nmol/l
5.4
12.4
—
7
58
(3020682) Albumin/Creatinine [Ratio] in Urine
56
543
1.04
0.06
3.8
3.8
mg/mmol
1.9
8.1
3.18
32
313
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
43
416
1.04
0.05
2.7
2.0
mg/l
2.4
3.3
2.49
37
362
(3032080) INR in Blood by Coagulation assay
70
685
1.03
0.05
10.2
8.7
inr
1.2
1.2
0.11
23
192
(3021601) Nitrite [Presence] in Urine by Test strip
88
865
1.03
0.05
4.7
5.0
estimate
0.0
0.0
0.00
14
145
(3011397) Hemoglobin [Presence] in Urine by Test strip
39
400
0.97
0.03
4.2
3.6
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
12
113
1.07
0.02
1.0
1.2
iu/ml
82.2
175.4
—
6
53
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
38
387
0.98
0.01
1.2
1.2
u/ml
2.4
1.6
—
9
113
(3035350) Ketones [Presence] in Urine by Test strip
85
857
0.99
0.01
3.4
3.6
estimate
0.0
0.0
0.00
15
150
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
33
336
0.98
0.00
1.3
1.4
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
36
354
1.02
0.00
1.2
1.4
g/l
2.3
2.4
0.10
14
204
(3009261) Glucose [Presence] in Urine by Test strip
88
874
1.01
0.00
3.3
3.6
estimate
0.0
0.0
0.00
15
142
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
10
101
0.99
0.00
1.1
1.3
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
22
216
1.02
0.00
4.1
6.1
mmol/l
104.3
103.9
0.19
22
209
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
52
519
1.00
0.00
4.2
3.0
ng/l
1119.4
1184.6
0.08
44
438
(36660697) Celiac disease serology panel - Serum
13
127
1.03
0.00
1.1
1.1
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
24
237
1.01
0.00
1.3
1.2
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
34
343
0.99
0.00
1.8
1.7
nmol/l
1238.2
1192.6
0.07
19
253
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
37
373
0.99
0.00
1.6
1.8
pmol/l
526.3
455.8
0.67
32
313
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
12
118
1.02
0.00
1.4
1.2
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
12
115
1.05
0.00
1.7
1.6
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
11
105
1.05
0.00
1.5
1.5
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
0
7
0.00
0.00
0.0
2.7
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(4211845)
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
8
83
0.96
0.00
2.1
1.8
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(44806420)
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
0
7
0.00
0.00
0.0
2.1
—
70.1
—
0
7
(3017569) Oxygen content in Arterial blood
0
9
0.00
0.00
0.0
9.1
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.4
—
32.0
—
0
8
(3013727) Leukocytes other/100 leukocytes in Blood
0
8
0.00
0.00
0.0
4.0
—
47.9
—
0
8
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
0
5
0.00
0.00
0.0
1.2
—
6.0
—
0
5
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(1002224) Polysomnography panel
6
62
0.97
0.00
1.0
1.1
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4198724)
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
0
8
0.00
0.00
0.0
2.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
6
61
0.98
0.00
1.5
1.8
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
0
8
0.00
0.00
0.0
1.4
—
30.3
—
0
8
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017704) Immunofixation for Urine
0
9
0.00
0.00
0.0
2.2
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
8
82
0.97
0.00
1.4
2.4
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
6
59
1.02
0.00
2.2
1.5
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
0
8
0.00
0.00
0.0
2.3
—
2.3
—
0
8
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_INSITU_MELANOMA_LOWERLIMB – Melanoma in situ of lower limb, including hip
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).